News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–35
Matches
35
Sources here
13
Companies here
1
Search results Stored financial headlines

Active search

35 matching headlines

Ticker or company: TNONMain company stories
Clear
Latest

Stock Titan Deals and strategy

Armistice Capital reports 9.99% ownership of Tenon Medical (TNON) through Master Fund

Armistice Capital, LLC and Steven Boyd have reported a 9.99% beneficial ownership stake in Tenon Medical, Inc. (TNON) through Armistice Capital Master Fund Ltd. This ownership, totaling 54,554 shares, grants them shared voting and dispositive power. The filing specifies that the Master Fund retains the right to receive dividends and sale proceeds.

Tenon outlines sacropelvic launches over next six to nine months following FDA 510(k) clearance

Earnings Call Insights: Tenon Medical (TNON) Q2 2026 MANAGEMENT VIEW * "Second quarter revenue was $1.3 million, an increase of 127% over the second quarter last year, and gross profit was $0.8 million, an increase of 232% over the prior year period." (CEO, President …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Earnings call transcript: Tenon Medical posts strong growth in Q2 2026

Tenon Medical reported strong revenue growth of 127% year-over-year in Q2 2026, reaching $1.3 million, but still posted a wider net loss of $4.1 million and missed analyst expectations for both revenue and earnings. Despite the financial miss, the company saw significant gross margin …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical, Inc. 2Q 2026: Revenue $1.279M, Net loss $(4.05M), EPS $(12.35) — 10-Q Summary

Tenon Medical, Inc. reported its second-quarter 2026 results, showing revenue of $1.279 million, a net loss of $(4.05 million), and a diluted loss per share of $(12.35). Revenue more than doubled year-over-year, driven by increased procedure volumes and the acquisition of the SImmetry+ System. …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical (TNON) lifts SI joint revenue but flags going-concern risk

Tenon Medical (TNON) reported increased revenue for the quarter ended June 30, 2026, reaching $1.3 million, up from $0.6 million a year prior, driven by higher SI joint procedure volumes and contributions from its SImmetry+ system. Despite revenue growth and improved gross margins, the …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Q2 Revenue Rises 127% to $1.3 Million

Tenon Medical (TNON) reported a significant increase in its Q2 2026 revenue, rising 127% to $1.3 million, with gross profit up 232% to $0.8 million. The company also announced FDA 510(k) clearance for its updated Catamaran SI Joint Fusion System and completed a $4.2 …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical (TNON) posts 127% Q2 2026 revenue growth amid higher net loss

Tenon Medical reported a significant revenue increase of 127% to $1.3 million in Q2 2026, driven by higher surgical procedures and the SImmetry®+ System, alongside an improved gross margin of 64%. Despite this growth, the company's net loss widened to $4.1 million, and it …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Reports Second Quarter 2026 Financial Results

Tenon Medical (NASDAQ:TNON) announced its second quarter 2026 financial results, reporting a 127% increase in revenue to $1.3 million and a 232% increase in gross profit to $0.8 million compared to the prior year. The company also received FDA 510(k) clearance for its updated …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings To Watch: Tenon Medical Inc (TNON) Q2 2026 -- GF Value Sees 89% Downside

Tenon Medical Inc (TNON) is scheduled to release its Q2 2026 earnings on August 13, 2026, with anticipated revenues of $1.54 million and earnings of -0.24 per share. Analyst estimates for both revenue and earnings for 2026 and 2027 have seen slight increases over …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Announces Reverse Stock Split to Maintain Listing

Tenon Medical, Inc. (TNON) has announced a 1-for-35 reverse stock split, effective August 10, 2026, to meet Nasdaq's minimum $1.00 per-share requirement and maintain its listing. The company specializes in medical devices for sacro-pelvic disorders, marketing the Catamaran and SImmetry+ SI Joint Fusion Systems. …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K Tenon Medical Inc For: 10 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by Tenon Medical Inc for August 10th. The brief piece includes the stock symbol TNON and a minor price change. The core content is a straightforward notification of the SEC filing.

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical (TNON) launches 1-for-35 reverse stock split to lift share price

Tenon Medical (TNON) has enacted a 1-for-35 reverse stock split, effective August 10, 2026, to increase its share price and meet Nasdaq's minimum listing requirement of $1.00. Each 35 shares of common stock were combined into one, with fractional shares rounded up. The stock …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Implements 1-for-35 Reverse Stock Split; Today

(RTTNews) - Tenon Medical, Inc. (TNON) announced on Thursday, August 6, 2026, that it will implement a 1-for-35 reverse stock split today effective at 12:01, Eastern Time, on August 10, 2026. The company confirmed that its shares will begin trading on a split-adjusted basis …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical targets Nasdaq's $1 minimum with a 1-for-35 split

Tenon Medical (NASDAQ: TNON) has announced a 1-for-35 reverse stock split, effective August 10, 2026, to meet Nasdaq's minimum $1.00 average closing price requirement for continued listing. The split will convert 35 pre-split shares into one post-split share, with fractional shares rounded up. Shareholders …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical announces 1-for-35 reverse stock split By Investing.com

Tenon Medical, Inc. has announced a 1-for-35 reverse stock split of its common stock, effective August 10, 2026, before trading begins on the Nasdaq Capital Market. The primary goal of this action is to increase the per share market price to meet Nasdaq's minimum …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical schedules Q2 results call for Aug. 13 at 4:30 p.m.

Tenon Medical (NASDAQ: TNON) will release its second quarter 2026 financial results on Thursday, August 13, 2026, after market close, covering the period ended June 30, 2026. A conference call featuring a Q&A with analysts will follow at 4:30 p.m. Eastern Time. Investors can …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

Tenon Medical, Inc. announced it will release its financial results for the second quarter ended June 30, 2026, after market close on Thursday, August 13, 2026. The company will also host a conference call at 4:30 p.m. Eastern Time on the same day to …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Inc (TNON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Tenon Medical Inc (TNON), detailing its stock performance and market capitalization. It indicates that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page also offers general …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical, Inc. Revenue Breakdown – NASDAQ:TNONW

Tenon Medical, Inc. (NASDAQ: TNONW) generated $3.94 million USD in revenue last year, primarily from its Surgical Implant-system segment, an increase from $3.28 million USD the previous year. All of this revenue was contributed by the United States market.

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Inc (TNON) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Tenon Medical Inc (TNON), providing an overview of its major individual and institutional holders. It lists the proportion of shares held by various shareholder types and tracks institutional shareholding changes over several quarters, alongside specific shareholder activity …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Inc TNON Cash Flow Statement

This article provides a detailed cash flow statement for Tenon Medical Inc (TNON), presenting both quarterly and annual data for operating, investing, and financing activities. It includes line items such as net income, changes in working capital, capital expenditures, debt issuance/repayment, and free cash …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Inc|Price:0.190|Chg%:-0.007

Tenon Medical Inc. (TNON) has been assessed by TradingKey, which highlights relatively healthy fundamentals and high growth potential despite a recent dip in stock price. The company's valuation is considered fair, and it boasts high institutional ownership with analysts giving it a "Buy" rating …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical (NASDAQ: TNON) holders approve reverse split, financings

Tenon Medical, Inc. stockholders approved a reverse stock split, debt financing, and future financing proposals at their 2026 Annual Meeting. All director nominees were also elected and the auditor appointment was ratified. While the proposals for financing were approved, the 8-K filing only discloses …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TNON: All director nominees and proposals were approved, with no questions raised by stockholders

During Tenon Medical, Inc.'s 2026 AGM, all director nominees and six key proposals were approved, with the results slated for SEC filing. Stockholders did not raise any questions during the session. This summary is based on the company's audio transcript from July 23, 2026.

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical (TNON) AGM 2026 Summary

This article provides a summary of Tenon Medical's (TNON) 2026 Annual General Meeting (AGM), held on July 23, 2026. Key topics included the CEO's opening remarks, board and executive committee updates, and shareholder proposals. The board recommended approval of six proposals, including the election …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical regains Nasdaq compliance on equity rule By Investing.com

Tenon Medical Inc. has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million following a $4.2 million public offering of common stock and warrants. The company had previously received a warning from Nasdaq regarding non-compliance. Despite being near its 52-week low, InvestingPro …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical Regains Nasdaq Stockholders’ Equity Compliance After $4.2M Offering

Tenon Medical has regained compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement following a $4.2 million public offering of common stock and warrants. The company was notified of its compliance on July 17, 2026, but must maintain this status through its upcoming 10-Q …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical regains Nasdaq equity compliance | TNON 8-K Filing

Tenon Medical Inc. (TNON) has regained compliance with Nasdaq's continued listing requirement to maintain at least $2.5 million in stockholders’ equity, as confirmed by a Nasdaq notice on July 17, 2026. This compliance was achieved following a $4.2 million public offering of common stock …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement

Tenon Medical, Inc. announced that it has regained compliance with Nasdaq's minimum stockholders' equity requirement. This compliance was achieved through a $4.2 million public offering of common stock and warrants completed on July 1, 2026. However, the company faces potential delisting if it fails …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A $4.2M offering helped Tenon Medical meet a Nasdaq rule

Tenon Medical announced it has regained compliance with Nasdaq's $2.5 million stockholders' equity requirement following a $4.2 million public offering of common stock and warrants completed on July 1, 2026. The company received official notification from Nasdaq on July 17, 2026. However, continued compliance …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical (TNON) Proxy filing Summary

Tenon Medical's 2026 Annual Meeting will be held virtually on July 23, 2026, with key proposals including director elections, auditor ratification, a reverse stock split, and approval for debt and future financings. The Board recommends voting in favor of all proposals, citing alignment with …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tenon Medical (TNON) Registration filing Summary

This article summarizes Tenon Medical's (TNON) registration filing, detailing its focus on minimally invasive medical devices for SI joint disorders with products like the Catamaran and SImmetry systems. The company recently expanded its product portfolio through acquisitions and raised $2.85 million in November 2025. …

TNON main company
Sharemaestro market context Price below Trend Line 52 weeks -90.1% · Next-week setup negative 36.5% TNON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context